CLINICAL_TRIALS
trial_result
· 2010-02-10
Clinical Trial Update: Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain [Phase 3]
Summary
A Phase 3 trial evaluating Oxymorphone Extended Release (ER) in opioid-naive patients with chronic pain has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endo Pharmaceuticals | Conditions: Pain, Chronic Disease | Phase 3 | Status: COMPLETED